Rapid Dose Therapeutics Corp. (CSE:DOSE)
Canada · Delayed Price · Currency is CAD 0.1000
-0.0050 (-4.76%)
Sep 18, 2026, 12:37 PM EST
Rapid Dose Therapeutics Market Cap
Rapid Dose Therapeutics has a market cap or net worth of CAD 13.64 million as of September 18, 2026. Its market cap has decreased by -37.76% in one year.
Market Cap
13.64M
Enterprise Value
19.44M
Revenue
2.58M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.10
ChartMarket Cap Chart
Since December 17, 2018, Rapid Dose Therapeutics's market cap has decreased from 63.77M to 13.64M, a decrease of -78.60%. That is a compound annual growth rate of -18.02%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 18, 2026 | 13.64M | -22.70% |
| Dec 31, 2025 | 17.65M | -37.53% |
| Dec 31, 2024 | 28.26M | 63.18% |
| Dec 29, 2023 | 17.32M | -67.57% |
| Dec 31, 2021 | 53.40M | 110.14% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 17, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Pharmala Biotech Holdings | 29.07M |
| The More Life Company | 27.42M |
| Lobe Sciences | 25.47M |
| Devonian Health Group | 23.98M |
| Alzai Health | 23.97M |
| Hemostemix | 15.86M |
| PreveCeutical Medical | 12.76M |
| Britannia Life Sciences | 11.52M |